Innovative Converged Devices (ICD) unveiled Vega, their first in a future line of Android products of low priced, full featured High Definition entertainment and information devices that feature 3G ...

In literature reports on the implantation of ICD/PM (pacemakers) and SCSs, no adverse events attributable to interaction between the two devices have been described.

Biegelsen estimated worldwide sales of the S-ICD device to be $46 million in 2013. Boston Scientific had sales of $5.4 billion in the first nine months of 2012.

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

This study demonstrates that psychological distress was not significantly increased in patients recently informed about a potential malfunction of their device.

The FDA announced Medtronic has issued a recall of its implantable cardioverter defibrillators and cardiac resynchronization therapy devices due to a short circuit protection alert resulting in ...

For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...

Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial ...

The number of patients undergoing implantation of a cardioverter-defibrillator (ICD) is increasing, as the indications for device therapy have broadened. Despite the mortality benefits associated ...

“In our cohort of 629 patients with non–MRI-conditional ICD devices prospectively followed after MRI, we found no direct evidence of ICD failure to deliver therapy,” the researchers wrote.